Work on High-Speed Vaccine Factories Prompts Questions

Global Security Newswire Staff
April 30, 2014, 9:49 a.m.

Spe­cial­ists are ques­tion­ing the feas­ib­il­ity of three U.S. factor­ies be­ing built to rap­idly turn out drugs needed after an at­tack or dis­aster, Nature re­ports.

Cer­tain ana­lysts ar­gued that few use­ful an­ti­dotes are cur­rently avail­able for re­spond­ing to the types of bio­lo­gic­al and chem­ic­al events en­vi­sioned by the pro­duc­tion fa­cil­it­ies un­der pre­par­a­tion in Texas, North Car­o­lina and Mary­land, the journ­al re­por­ted on Tues­day. Ob­serv­ers also cast doubt on the util­ity of next-gen­er­a­tion small­pox vac­cines, as well as oth­er drugs that may be pro­duced at the so-called Cen­ters for In­nov­a­tion in Ad­vanced De­vel­op­ment and Man­u­fac­tur­ing.

The United States is re­l­at­ively un­likely to face a chem­ic­al or bio­lo­gic­al strike for which the factor­ies would prove use­ful, ar­gued Richard Ebright, a mo­lecu­lar bio­lo­gist with Rut­gers Uni­versity. The Texas plant is slated to be­gin gen­er­at­ing its first vac­cine in the middle of this year, and fed­er­al of­fi­cials plan in the next quarter-cen­tury to spend up to $2 bil­lion on med­ic­al treat­ments from that single fa­cil­ity.

Philip Rus­sell, a former biode­fense ad­viser for the George W. Bush ad­min­is­tra­tion, sug­ges­ted the United States should have built just one such pro­duc­tion site for ci­vil­ian and mil­it­ary needs, in line with a 2008 re­com­mend­a­tion by the Pentagon’s De­fense Ad­vanced Re­search Pro­jects Agency.

“Rather than one good op­er­a­tion that meets the gov­ern­ment’s needs, we got three op­er­a­tions that spread the money around,” Rus­sell said of the $440 mil­lion ini­ti­at­ive, launched in 2012 by the Health and Hu­man Ser­vices De­part­ment.

The cur­rent plan’s back­ers, mean­while, ar­gued that op­er­at­ing sev­er­al man­u­fac­tur­ing plants would provide a fall­back if one is com­prom­ised by a strike or re­lease of haz­ard­ous ma­ter­i­al.

In ad­di­tion to the three sites over­seen by Health and Hu­man Ser­vices, the De­fense De­part­ment is con­struct­ing a $136 mil­lion fact­ory in Flor­ida to gen­er­ate smal­ler quant­it­ies of biode­fense products for armed-forces use. That site is ex­pec­ted to op­er­ate at an an­nu­al cost of $20 mil­lion fol­low­ing its sched­uled launch in 2015.

What We're Following See More »
Trump Finance Guru Has History of Contributing to Dems
7 minutes ago

"Like Donald Trump himself, the Trump campaign’s new national finance chairman has a long history of contributing to Democrats—including Hillary Clinton. Private investor Steven Mnuchin, Trump’s new campaign fundraising guru, has contributed more than $120,000" to candidates since 1995, about half of which has gone to Democrats.

Paul Ryan Can’t Get Behind Trump
16 hours ago

Paul Ryan told CNN today he's "not ready" to back Donald Trump at this time. "I'm not there right now," he said. Ryan said Trump needs to unify "all wings of the Republican Party and the conservative movement" and then run a campaign that will allow Americans to "have something that they're proud to support and proud to be a part of. And we've got a ways to go from here to there."

Trump Roadmapped His Candidacy in 2000
18 hours ago

The Daily Beast has unearthed a piece that Donald Trump wrote for Gear magazine in 2000, which anticipates his 2016 sales pitch quite well. "Perhaps it's time for a dealmaker who can get the leaders of Congress to the table, forge consensus, and strike compromise," he writes. Oddly, he opens by defending his reputation as a womanizer: "The hypocrites argue that a man who loves and appreciates beautiful women (and does so legally and openly) shouldn't become a national leader? Is there something wrong with appreciating beautiful women? Don't we want people in public office who show signs of life?"

Sen. Murphy: Trump Shouldn’t Get Classified Briefigs
18 hours ago
Romney to Skip Convention
19 hours ago

An aide to Mitt Romney confirmed to the Washington Post that the 2102 GOP nominee will not attend the Republican convention this year. He joins the two living Republican presidents, George W. Bush and George H.W. Bush, as well as 2008 nominee John McCain in skipping the event. Even among living Republican nominees, that leaves only Bob Dole who could conceivably show up. Dole did say in January that he'd prefer Trump to Ted Cruz, but his age (92) could keep him from attending.